12.40Open13.90Pre Close4 Volume4 Open Interest65.00Strike Price5.02KTurnover4670.23%IV0.53%PremiumDec 13, 2024Expiry Date12.19Intrinsic Value100Multiplier-2DDays to Expiry0.41Extrinsic Value100Contract SizeAmericanOptions Type0.9785Delta0.0077Gamma6.35Leverage Ratio-126.4597Theta0.0000Rho6.22Eff Leverage0.0001Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet